PG&E Sets Dates for Quarterly Stock Dividends
Werte in diesem Artikel
OAKLAND, Calif., Dec. 12, 2025 /PRNewswire/ -- On December 11, 2025, PG&E Corporation (NYSE: PCG) declared its fourth quarter 2025 regular cash dividend of $0.05 per share on the Corporation's common stock. The dividend is payable on January 15, 2026, to shareholders of record as of December 31, 2025.
In addition, PG&E Corporation's utility subsidiary, Pacific Gas and Electric Company (PG&E), declared the regular preferred stock dividend for the three-month period ending January 31, 2026, to be payable on February 15, 2026, to shareholders of record as of January 30, 2026. PG&E will pay dividends on its eight series of preferred stock as follows:
First Preferred Stock, | Quarterly Dividend to | ||
Redeemable | |||
5.00 % | $0.31250 | ||
5.00% Series A | $0.31250 | ||
4.80 % | $0.30000 | ||
4.50 % | $0.28125 | ||
4.36 % | $0.27250 | ||
Non-Redeemable | |||
6.00 % | $0.37500 | ||
5.50 % | $0.34375 | ||
5.00 % | $0.31250 |
About PG&E Corporation
PG&E Corporation (NYSE: PCG) is a holding company headquartered in Oakland, California. It is the parent company of Pacific Gas and Electric Company, an energy company that serves 16 million Californians across a 70,000-square-mile service area in Northern and Central California. For more information, visit http://www.pgecorp.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pge-sets-dates-for-quarterly-stock-dividends-302639643.html
SOURCE PG&E Corporation
Übrigens: PG&E und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf PG&E
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf PG&E
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
